Changes on brief cognitive instruments over time in Parkinson's disease

被引:72
作者
Lessig, Stephanie [1 ,2 ]
Nie, Dong [3 ]
Xu, Ronghui [3 ,4 ,5 ]
Corey-Bloom, Jody [1 ]
机构
[1] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA
[2] VA Med Ctr San Diego, San Diego, CA USA
[3] Univ Calif San Diego, Clin & Translat Res Inst, Biostat Unit, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA
[5] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA
关键词
Parkinson's Disease; MMSE; MoCA; cognition; MENTAL-STATE-EXAMINATION; SCREENING TOOL; IMPAIRMENT; DEMENTIA; MOCA; DONEPEZIL; MMSE;
D O I
10.1002/mds.25070
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Two hundred and twenty-one subjects with Parkinson's disease (PD) were examined using the MiniMental Status Examination (MMSE) and Montreal Cognitive Assessment (MoCA), with a subset of these (n = 98) examined on repeat testing up to 3 years. The MoCA was more sensitive in identifying cognitive deficit, specifically in the domains of visuospatial abilities, language, and memory. In longitudinal study, the MMSE changed significantly over time, particularly in patients with disease duration of >10 years. The MoCA, however, did not change significantly, even when subjects were stratified by age, MMSE score, and disease duration. This suggests that the MoCA may be more sensitive for detecting early cognitive change in PD, but that the MMSE, and not the MoCA, may be better for tracking cognitive decline. (c) 2012 Movement Disorder Society
引用
收藏
页码:1125 / 1128
页数:4
相关论文
共 18 条
  • [1] Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
    Aarsland, D
    Laake, K
    Larsen, JP
    Janvin, C
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (06) : 708 - 712
  • [2] Nonlinear Decline of Mini-Mental State Examination in Parkinson's Disease
    Aarsland, Dag
    Muniz, Graciela
    Matthews, Fiona
    [J]. MOVEMENT DISORDERS, 2011, 26 (02) : 334 - 337
  • [3] A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson's Disease
    Chou, Kelvin L.
    Amick, Melissa M.
    Brandt, Jason
    Camicioli, Richard
    Frei, Karen
    Gitelman, Darren
    Goldman, Jennifer
    Growdon, John
    Hurtig, Howard I.
    Levin, Bonnie
    Litvan, Irene
    Marsh, Laura
    Simuni, Tanya
    Troester, Alexander I.
    Uc, Ergun Y.
    [J]. MOVEMENT DISORDERS, 2010, 25 (15) : 2501 - 2507
  • [4] The MoCA Well-suited screen for cognitive impairment in Parkinson disease
    Dalrymple-Alford, J. C.
    MacAskill, M. R.
    Nakas, C. T.
    Livingston, L.
    Graham, C.
    Crucian, G. P.
    Melzer, T. R.
    Kirwan, J.
    Keenan, R.
    Wells, S.
    Porter, R. J.
    Watts, R.
    Anderson, T. J.
    [J]. NEUROLOGY, 2010, 75 (19) : 1717 - 1725
  • [5] DAVIES RB, 1987, BIOMETRIKA, V74, P33, DOI 10.2307/2336019
  • [6] Diagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society Task Force
    Dubois, Bruno
    Burn, David
    Goetz, Christopher
    Aarsland, Dag
    Brown, Richard G.
    Broe, Gerald A.
    Dickson, Dennis
    Duyckaerts, Charles
    Cummings, Jefferey
    Gauthier, Serge
    Korczyn, Amos
    Lees, Andrew
    Levy, Richard
    Litvan, Irene
    Mizuno, Yoshikuni
    McKeith, Ian G.
    Olanow, C. Warren
    Poewe, Werner
    Sampaio, Cristina
    Tolosa, Eduardo
    Emre, Murat
    [J]. MOVEMENT DISORDERS, 2007, 22 (16) : 2314 - 2324
  • [7] The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease
    Gill, David J.
    Freshman, Arielle
    Blender, Jennifer A.
    Ravina, Bernard
    [J]. MOVEMENT DISORDERS, 2008, 23 (07) : 1043 - 1046
  • [8] Utility of the NeuroTrax Computerized Battery for Cognitive Screening in Parkinson's Disease: Comparison with the MMSE and the MoCA
    Hanna-Pladdy, B.
    Enslein, A.
    Fray, M.
    Gajewski, B. J.
    Pahwa, R.
    Lyons, K. E.
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2010, 120 (08) : 538 - 543
  • [9] Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
    Hoops, S.
    Nazem, S.
    Siderowf, A. D.
    Duda, J. E.
    Xie, S. X.
    Stern, M. B.
    Weintraub, D.
    [J]. NEUROLOGY, 2009, 73 (21) : 1738 - 1745
  • [10] CLINICAL-SIGNIFICANCE - A STATISTICAL APPROACH TO DEFINING MEANINGFUL CHANGE IN PSYCHOTHERAPY-RESEARCH
    JACOBSON, NS
    TRUAX, P
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1991, 59 (01) : 12 - 19